The medicament for treating hyperphospheremia and preparation thereof

Details for Australian Patent Application No. 2006341171 (hide)

International Classifications

Event Publications

16 October 2008 PCT application entered the National Phase

PCT publication WO2007/109929 Priority application(s): WO2007/109929

3 June 2010 Application Accepted

Published as AU-B-2006341171

29 July 2010 Assignment before Grant

Zhang, Weisheng; Li, Shibiao; Qiao, Min The application has been assigned to Liaoning Nuokang Bio-pharmaceutical Co., Ltd

30 September 2010 Standard Patent Sealed

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

12 April 2012 Section 223 Application Received

Liaoning Nuokang Bio-pharmaceutical Co., Ltd An application to extend the time from 26 Jun 2011 to 26 Feb 2012 in which to pay a renewal has been filed . Address for service in Australia - FB Rice Level 23 200 Queen Street Melbourne VIC 3000 2010

31 May 2012 Section 223 Application Allowed

Liaoning Nuokang Bio-pharmaceutical Co., Ltd The time in which to pay a renewal has been extended to 26 Feb 2012. Address for service in Australia - FB Rice Level 23 200 Queen Street Melbourne VIC 3000 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.